Niagen Bioscience, Inc. (NAGE)
(Delayed Data from NSDQ)
$9.04 USD
-0.31 (-3.32%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $9.04 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
NAGE 9.04 -0.31(-3.32%)
Will NAGE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NAGE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NAGE
Niagen Bioscience (NAGE) Q1 Earnings and Revenues Beat Estimates
NAGE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NAGE
Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 ...
Niagen Bioscience (NAGE) Secures Exclusive License Agreement
Niagen Bioscience signs license deal with Haukeland University
Niagen Bioscience licenses potential Parkinson's therapy